Pierre Fabre SA - Company & Market Research Reports

Pierre Fabre develops, produces, and markets pharmaceutical products for customers in France and internationally. It is the second largest dermo-cosmetics lab in the world and the 2nd largest private French pharmaceutical group. It has subsidiaries in 43 countries and distribution agreements in over 130 countries. The company offers prescription drugs for various treatment fields, such as urology, gynecology, diabetes, cardiology and others. The company was founded in 1951 and is based in Paris, France.


Iressa - Gefitinib - Oncology Drug Report - 2002-2015 Analysis; 2016-2021 Expectations - Product Thumbnail Image

Iressa - Gefitinib - Oncology Drug Report - 2002-2015 Analysis; 2016-2021 Expectations

  • Report
  • 42 Pages
From
Bladder and Ureter Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Bladder and Ureter Cancer Drug Development Pipeline Review, 2017

  • Report
  • 150 Pages
From
Over-the-Counter (OTC) Drugs and Dietary Supplements: Global Markets - Product Thumbnail Image

Over-the-Counter (OTC) Drugs and Dietary Supplements: Global Markets

  • Report
  • 150 Pages
From
Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016 - Product Thumbnail Image

Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016

  • Report
  • 722 Pages
From
Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016 - Product Thumbnail Image

Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016

  • Report
  • 713 Pages
From
Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Insight, 2018 - Product Thumbnail Image

Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015 - Product Thumbnail Image

Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

  • Report
  • 515 Pages
From
Oncology Drug Report - Xalkori - Crizotinib - 2011-2015 Analysis; 2016-2021 Expectations - Product Thumbnail Image

Oncology Drug Report - Xalkori - Crizotinib - 2011-2015 Analysis; 2016-2021 Expectations

  • Report
  • 48 Pages
From
Xerosis - Pipeline Insight, 2018 - Product Thumbnail Image

Xerosis - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
OTC Bulletin: The Business Newsletter for the Consumer Healthcare Industry - Product Thumbnail Image

OTC Bulletin: The Business Newsletter for the Consumer Healthcare Industry

  • Newsletter
  • 28 Pages
From
2018 Atrial Fibrillation Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Atrial Fibrillation Drug Development- Pipeline Analysis Report

  • Report
  • 70 Pages
From
Fibromyalgia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Fibromyalgia Therapeutics - Global Strategic Business Report

  • Report
  • 78 Pages
From
T-Cell Immunotherapy Market (2nd Edition), 2017-2030 - Product Thumbnail Image

T-Cell Immunotherapy Market (2nd Edition), 2017-2030

  • Report
  • 654 Pages
From
Antibody Drug Conjugates Market (3rd Edition) - Product Thumbnail Image

Antibody Drug Conjugates Market (3rd Edition)

  • Report
  • 357 Pages
From
Antibody Drug Conjugates Market (4th Edition) 2017-2030 - Product Thumbnail Image

Antibody Drug Conjugates Market (4th Edition) 2017-2030

  • Report
  • 556 Pages
From
HPAPIs and Cytotoxic Drugs Manufacturing Market (2nd Edition), 2016 - 2026 - Product Thumbnail Image

HPAPIs and Cytotoxic Drugs Manufacturing Market (2nd Edition), 2016 - 2026

  • Report
  • 345 Pages
From
Drug analysis: Binimetinibi - Product Thumbnail Image

Drug analysis: Binimetinibi

  • Drug Pipelines
  • 27 Pages
From
Immune Checkpoint Inhibitors Market (2nd edition), 2015-2025 - Product Thumbnail Image

Immune Checkpoint Inhibitors Market (2nd edition), 2015-2025

  • Report
  • 401 Pages
From
Antibody-Drug Conjugates 2014 - A Business, Technology & Pipeline Analysis - Product Thumbnail Image

Antibody-Drug Conjugates 2014 - A Business, Technology & Pipeline Analysis

  • Report
  • 347 Pages
From
Malignant Mesothelioma - Pipeline Review, H1 2018 - Product Thumbnail Image

Malignant Mesothelioma - Pipeline Review, H1 2018

  • Report
  • 612 Pages
From
Loading Indicator
adroll